Yoon Jun Kim

Quick facts

Phase 3 pipeline

• GODEX · Diabetes
  GODEX is a small molecule that targets the SGLT2 receptor.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Yoon Jun Kim portfolio CI brief
• Yoon Jun Kim pipeline updates RSS